GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of Repatha® ...

Amgen has joined the wave of major drugmakers setting up direct-to-consumer programs amid President Donald Trump’s call for more DTC options to lower U.S. drug prices. The "AmgenNow" program, launched ...

Amgen makes Repatha available through AmgenNow, a direct-to-patient programme in the US: Thousand Oaks, California Wednesday, October 8, 2025, 17:00 Hrs [IST] Amgen announced the ...

Amgen on Monday launched direct-to-consumer U.S. sales of its cholesterol-lowering medication Repatha at a discounted cash ...

THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha ® (evolocumab). This follows ...

Cardiologists often struggle to assess heart attack risk. New startups using AI could help.

Amgen’s cholesterol-lowering shot Repatha met its main goals in a large trial evaluating use as a “primary prevention” therapy, besting a placebo at reducing the risk of cardiovascular events or death ...

Amgen’s phase 3 VESALIUS-CV trial meets primary endpoints in a cardiovascular primary prevention study of 12,000 patients: Thousand Oaks, California Saturday, October 4, 2025, 1 ...

Amgen said yesterday that its cholesterol-lowering injection Repatha cut the risk of a composite of heart disease death, ...

The British pharmaceutical giant has joined the direct-to-consumer push, following Pfizer and Amgen’s announcements in ...